BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23082627)

  • 1. Haemolytic-uraemic syndrome as a sequela of diarrhoeal disease.
    Walker CL; Applegate JA; Black RE
    J Health Popul Nutr; 2012 Sep; 30(3):257-61. PubMed ID: 23082627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desperately seeking diarrhoea: outbreak of haemolytic uraemic syndrome caused by emerging sorbitol-fermenting shiga toxin-producing Escherichia coli O157:H-, Germany, 2009.
    Nielsen S; Frank C; Fruth A; Spode A; Prager R; Graff A; Plenge-Bönig A; Loos S; Lütgehetmann M; Kemper MJ; Müller-Wiefel DE; Werber D
    Zoonoses Public Health; 2011 Dec; 58(8):567-72. PubMed ID: 21824358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shiga toxin-induced haemolytic uraemic syndrome and the role of antibiotics: a global overview.
    Kakoullis L; Papachristodoulou E; Chra P; Panos G
    J Infect; 2019 Aug; 79(2):75-94. PubMed ID: 31150744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble plasma VE-cadherin concentrations are elevated in patients with STEC infection and haemolytic uraemic syndrome: a case-control study.
    Doulgere J; Otto B; Nassour M; Wolters-Eisfeld G; Rohde H; Magnus T; Wagener C; Streichert T
    BMJ Open; 2015 Mar; 5(3):e005659. PubMed ID: 25757942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low risk of hemolytic uremic syndrome after early effective antimicrobial therapy for Shigella dysenteriae type 1 infection in Bangladesh.
    Bennish ML; Khan WA; Begum M; Bridges EA; Ahmed S; Saha D; Salam MA; Acheson D; Ryan ET
    Clin Infect Dis; 2006 Feb; 42(3):356-62. PubMed ID: 16392080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemolytic uraemic syndrome in India due to Shiga toxigenic Escherichia coli.
    Kumar A; Taneja N; Singhi S; Shah R; Sharma M
    J Med Microbiol; 2013 Jan; 62(Pt 1):157-160. PubMed ID: 23002066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diarrhoea-associated haemolytic uraemic syndrome and Shiga toxin-producing Escherichia coli infections in New Zealand children: Clinical features and short-term complications from a 23-year cohort study.
    Wong W; Prestidge C; Dickens A; Ronaldson J
    J Paediatr Child Health; 2023 Mar; 59(3):493-498. PubMed ID: 36655863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A practical composite risk score for the development of Haemolytic Uraemic Syndrome from Shiga toxin-producing Escherichia coli.
    Hamilton D; Cullinan J
    Eur J Public Health; 2019 Oct; 29(5):861-868. PubMed ID: 31326985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Shiga-toxigenic Escherichia coli isolated from cases of diarrhoea & haemolytic uremic syndrome in north India.
    Kumar A; Taneja N; Bharti B; Sharma M
    Indian J Med Res; 2014 Dec; 140(6):778-84. PubMed ID: 25758577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody response to lipopolysaccharides and recombinant proteins of Shiga toxin (STX)-producing Escherichia coli (STEC) in children with haemolytic uraemic syndrome in Poland.
    Rastawicki W; Śmietańska K; Rokosz-Chudziak N; Wołkowicz T
    Lett Appl Microbiol; 2020 Jun; 70(6):440-446. PubMed ID: 32270510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eculizumab in the treatment of Shiga toxin haemolytic uraemic syndrome.
    Walsh PR; Johnson S
    Pediatr Nephrol; 2019 Sep; 34(9):1485-1492. PubMed ID: 30058046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Post-diarrheal haemolytic uremic syndrome: when shall we consider it? Which follow-up?].
    Bertholet-Thomas A; Ranchin B; King LA; Bacchetta J; Belot A; Gillet Y; Collardeau-Frachon S; Cochat P
    Arch Pediatr; 2011 Jul; 18(7):823-30. PubMed ID: 21571510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shiga toxin-producing Escherichia coli O171:H25 strain isolated from a patient with haemolytic uraemic syndrome.
    Lepšanović Z; Opačić D; Lazić S; Herpay M; Tóth S; Kostić M; Kucsera I
    Acta Microbiol Immunol Hung; 2012 Jun; 59(2):215-24. PubMed ID: 22750781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemolytic uremic syndrome due to Shiga toxin-producing Escherichia coli infection.
    Bruyand M; Mariani-Kurkdjian P; Gouali M; de Valk H; King LA; Le Hello S; Bonacorsi S; Loirat C
    Med Mal Infect; 2018 May; 48(3):167-174. PubMed ID: 29054297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infections in pediatric postdiarrheal hemolytic uremic syndrome: factors associated with identifying shiga toxin-producing Escherichia coli.
    Mody RK; Luna-Gierke RE; Jones TF; Comstock N; Hurd S; Scheftel J; Lathrop S; Smith G; Palmer A; Strockbine N; Talkington D; Mahon BE; Hoekstra RM; Griffin PM
    Arch Pediatr Adolesc Med; 2012 Oct; 166(10):902-9. PubMed ID: 22869280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of haemolytic uraemic syndrome caused by shiga-toxin-producing Escherichia coli infection in adult women in Japan.
    Fujii J; Mizoue T; Kita T; Kishimoto H; Joh K; Nakada Y; Ugajin S; Naya Y; Nakamura T; Tada Y; Okabe N; Maruyama Y; Saitoh K; Kurozawa Y
    Epidemiol Infect; 2016 Apr; 144(5):952-61. PubMed ID: 26470913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enterohaemorrhagic Escherichia coli and Shigella dysenteriae type 1-induced haemolytic uraemic syndrome.
    Mark Taylor C
    Pediatr Nephrol; 2008 Sep; 23(9):1425-31. PubMed ID: 18493800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virulence factors of Shiga toxin-producing Escherichia coli and the risk of developing haemolytic uraemic syndrome in Norway, 1992-2013.
    Naseer U; Løbersli I; Hindrum M; Bruvik T; Brandal LT
    Eur J Clin Microbiol Infect Dis; 2017 Sep; 36(9):1613-1620. PubMed ID: 28391537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of an outbreak of bloody diarrhea complicated with hemolytic uremic syndrome.
    Chokoshvili O; Lomashvili K; Malakmadze N; Geleishvil M; Brant J; Imnadze P; Chitadze N; Tevzadze L; Chanturia G; Tevdoradze T; Tsertsvadze T; Talkington D; Mody RK; Strockbine N; Gerber RA; Maes E; Rush T
    J Epidemiol Glob Health; 2014 Dec; 4(4):249-59. PubMed ID: 25455642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An epidemiologic surveillance of Shiga-like toxin-producing Escherichia coli infection in Argentinean children: risk factors and serum Shiga-like toxin 2 values.
    López EL; Contrini MM; Glatstein E; Ayala SG; Santoro R; Ezcurra G; Teplitz E; Matsumoto Y; Sato H; Sakai K; Katsuura Y; Hoshide S; Morita T; Harning R; Brookman S
    Pediatr Infect Dis J; 2012 Jan; 31(1):20-4. PubMed ID: 21829137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.